INCOME TAX9 Sept 2026
Pharma mutual funds: Kotak Healthcare leads 1-year returns at over 28% — here’s how others performed
Pharma and healthcare mutual funds have earned positive returns over the last year, but results vary widely. Kotak Healthcare led with 28.85%, while HDFC Pharma gave 28.60%. At the other end, ICICI Prudential Healthcare returned just 9.02%. The category average was 19.24%. If you hold such a fund, check where yours stands—performance depends heavily on stock selection.
Key Statutory Highlights
- Kotak Healthcare Fund gave the best one-year return of 28.85%, closely followed by HDFC Pharma and Healthcare Fund at 28.60%.
- ICICI Prudential Healthcare Fund was the weakest with 9.02%, while Tata India Pharma and Baroda BNP Paribas funds returned 10.62% and 12.81%.
- The pharma and healthcare fund category's average one-year return was 19.24%, showing a wide gap between top and bottom performers.
Actionable Advice for Taxpayers / Founders:If you are investing in a pharma or healthcare fund, compare its one-year return with the category average and talk to a SEBI-registered advisor before making any decision.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: